According to the latest study from BCC Research, "Proteomics: Technologies and Global Markets" was valued at $27.6 billion in ...

Opinion CBA’s big Texan backer explains why he’s all-in, despite the price “If it’s going to be in Australia, it’s got to be in Commonwealth,” says Ken Fisher, the billionaire ...

Key growth drivers include rising demands for high-sensitivity diagnostics and personalized medicine, advancements in ...

Appropriately, Fisher's firm, Fisher Investments, is located in a lush forest preserve in Woodside, California, where the contrarian-minded Fisher says he and his employees can get away from Wall ...

The global cell-based assays market is set to grow from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, marking a ...

Fisher Investments founder Ken Fisher has identified striking similarities between today’s economic landscape and the conditions seen in 1998. Speaking on Fox Business Network’s “Varney & Co ...

EXCLUSIVE: Some big news spanning independent film distribution and the Los Angeles agency scene: Teddy Schwarzman’s indie ...

Here’s where to find the winners as artificial intelligence transitions from an emerging technology to an adolescent one.

Download logo With Africa's upstream capital expenditure expected to reach $54 billion by 2030, the continent is gearing up for signi ...

Bradley Arant Boult Cummings added financial technology specialist Allison S. Cook from Arnall Golden Gregory this week in a ...

While early-stage life sciences companies attract Canadian investment dollars, those in the later stages of development have to rely more on global investors with deeper pockets. That’s according to a ...